These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Molecular and cellular biology of blood coagulation. Furie B; Furie BC N Engl J Med; 1992 Mar; 326(12):800-6. PubMed ID: 1538724 [No Abstract] [Full Text] [Related]
23. [Hemophilia A and von Willebrand disease]. Tanimoto M; Saito H Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):964-9. PubMed ID: 3152100 [No Abstract] [Full Text] [Related]
26. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions. Jacquemin M Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms of vitamin K antagonism. Bovill EG; Malhotra OP; Mann KG Baillieres Clin Haematol; 1990 Jul; 3(3):555-81. PubMed ID: 2271783 [No Abstract] [Full Text] [Related]
28. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Sadler JE; Shelton-Inloes BB; Sorace JM; Harlan JM; Titani K; Davie EW Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6394-8. PubMed ID: 2864688 [TBL] [Abstract][Full Text] [Related]
30. Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC). Ruggeri ZM; Nilsson IM; Lombardi R; Holmberg L; Zimmerman TS J Clin Invest; 1982 Nov; 70(5):1124-7. PubMed ID: 6982283 [TBL] [Abstract][Full Text] [Related]
31. [Research Progress on Genetic Factors and Hemophilia A Clotting Factor Inhibitor-Review]. Hu ZB; Sun X; He LY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):957-960. PubMed ID: 28641667 [TBL] [Abstract][Full Text] [Related]
32. The molecular basis of hereditary clotting disorders. Ratnoff OD Prog Hemost Thromb; 1972; 1():39-74. PubMed ID: 4571823 [No Abstract] [Full Text] [Related]
34. Correction of various abnormalities in cultured porcine von Willebrand endothelial cells by inhibition of plasminogen-dependent protease activity. Booyse FM; Quarfoot AJ; Radek J; Feder S Blood; 1981 Sep; 58(3):573-83. PubMed ID: 7020712 [No Abstract] [Full Text] [Related]
35. Primary structure of the propeptide and factor VIII-binding domain of bovine von Willebrand factor. Janel N; Ribba AS; Chérel G; Kerbiriou-Nabias D; Meyer D Biochim Biophys Acta; 1997 Apr; 1339(1):4-8. PubMed ID: 9165093 [TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor-like domains in the vitamin K-dependent clotting factors. Some structure-function relationships. Stenflo J; Ohlin AK; Persson E; Valcarce C; Astermark J; Drakenberg T; Selander M; Linse S; Björk I Ann N Y Acad Sci; 1991; 614():11-29. PubMed ID: 2024878 [No Abstract] [Full Text] [Related]
37. Comparison of albumin, colloid osmotic pressure, von Willebrand factor, and coagulation factors in canine cryopoor plasma, cryoprecipitate, and fresh frozen plasma. Culler CA; Iazbik C; Guillaumin J J Vet Emerg Crit Care (San Antonio); 2017 Nov; 27(6):638-644. PubMed ID: 29064153 [TBL] [Abstract][Full Text] [Related]
38. [Structural and functional analysis of mutant blood coagulation and fibrinolytic factors]. Miyata T Seikagaku; 1993 Apr; 65(4):223-47. PubMed ID: 8315307 [No Abstract] [Full Text] [Related]
39. [Rare hereditary types of hemophilia. Bleeding symptoms, family history and laboratory analyses indicates diagnosis]. Knobe K; Astermark J; Berntorp E; Hillarp A; Strandberg K; Svensson PJ Lakartidningen; 2011 Sep 21-27; 108(38):1819-23. PubMed ID: 22111212 [No Abstract] [Full Text] [Related]
40. Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene. Verweij CL; de Vries CJ; Distel B; van Zonneveld AJ; van Kessel AG; van Mourik JA; Pannekoek H Nucleic Acids Res; 1985 Jul; 13(13):4699-717. PubMed ID: 3875078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]